Cancer studies have proved that there is a relationship between statin use and lowered risk of having prostate cancer. This is according to relatively new studies. Strains were used over a long period in large doses for more aggressive tumors.
Statins are competitive inhibitors used as drugs to minimize cholesterol levels in patients to prevent the risk of having a heart attack. This drug has proven effective in this purpose and has been studied to find new ways it could cure other diseases.
Studies that have not gone into the clinical stage have shown that statins can slow down the rate at which tumors grow. However, the results collected are not conclusive that cancer can be eliminated. Some reports are not in support of this study and do not believe statins lower the risk of developing prostate cancer.
Other studies have analyzed the function statin plays in the chances of developing prostate cancer again. Fortunately, the findings were not conclusive and accurate. While this is so, other results have proved a lesser risk of biochemical recurrence once treatment is done. In some countries such as Denmark, statin use is linked with lowered cancer-related deaths in cancer patients.
Prostate cancer consists of a major part of almost all common malignant tumors found among men in developed countries and comes only second among men of Asian descent. In spite of early detection, it still proves a threat. This is why more research on statin needs to be a priority for cancer specialists.
The use of statins before cancer is diagnosed shows that there is a 15 percent chance of patients surviving than those who did not take a statin. Recently, studies have pointed out there is a link between statin therapy and how it has worked to produce optimistic outcomes of lowering prostate cancer.